Case
A 56 year old female presented to her primary care physician with a painless finger mass. She first noticed the mass about 7 years ago and it had been growing slowly since that time. Her former primary care physician had removed the mass about 5 years prior. She recalled being told at that time that it was a "ganglion cyst." The mass had since returned and grown back to its former size. It was not frankly painful, though it did feel tight and often got in the way of daily tasks. She denied any numbness or tingling in her finger, and denied any warmth, redness or swelling in her other joints. Her past medical and family histories were non-contributory, including no history of gout, autoimmune disease, or cancer. Physical examination revealed a non-tender, soft, well circumscribed mass on the extensor aspect of the right fifth digit, just proximal to the base of her fingernail ( Figure 1A ). The mass was approximately 2cm x 2cm and did not transilluminate ( Figure 1B ). The mass was fluctuant and encapsulated. There was no swelling or effusion in the hand, fingers, or joints. Neurologic exam showed no sensory or motor deficits.
The radiograph showed a non-invasive soft tissue mass on the dorsal aspect of the fifth distal phalanx ( Figure 1C ). Incisional biopsy was performed. The mass was found to be composed of non-encapsulated fatty tissue, and extended to the extensor tendon sheath. The patient was referred to hand surgery for a definitive excision.
Histological findings
Gross examination of the specimen revealed multiple fragments of lobulated and rubbery tissue which were mostly white to grey with focal yellow areas. Histological examination of the specimen stained with hematoxylin-eosin revealed an encapsulated benign neoplasm. The mass was composed of synovial-like mononuclear cells, with a variable number of multinucleate osteoclast-like cells (Figure 2A) , and foam cells ( Figure 2C ). Both the mononuclear cells and the giant cells showed strong reactivity for CD68 ( Figure 2B ). These findings are consistent with a diagnosis of tenosynovial giant cell tumor, localized type (giant cell tumor of tendon sheath).
Commentary
Tenosynovial giant cell tumor (TGCT) is a rare pathologic entity affecting the synovium and tendon sheath in adults [1] [2] [3] . Tenosynovial giant cell tumors can present as localized or diffuse to the synovium of the tendon sheath or interphalangeal joint especially on volar surfaces. TGCT of the tendon sheath falls second behind the ganglion cyst as the most common soft tissue tumor in the hand. There is a 2:1 female predominance, with most patients affected between the ages of 30-50 2 . Surgery is the treatment of choice, with marginal excision as the preferred method for a localized lesion 4 . Localized lesions generally do not behave aggressively and can be treated with re-excision 1, 2, 5 . Larger lesions may be found intra-articular with the most common site being the knee. Other sites include the wrist, ankle, and foot 1 . Recurrences may occur approximately 25% (5-44%) of the time. It is unclear what factors cause recurrence, but age, sex, location within the digit and size of the lesion do not affect risk of recurrence 5 . Several factors may be associated with an increased recurrence rate. These include increased cellularity and mitotic activity, a specific gene profile (negative for nm23), adjacent joint degenerative disease, and location on the thumb IP joints, digital DIP joints, flexor tendon, extensor tendon, or joint capsule. All of these factors have been both supported and refuted as carrying an increased risk of recurrence in various studies. The literature does suggest that type II tumors, and tumors which were incompletely excised are more prone to recurrence. It appears that factors which increase the difficulty of complete excision, as well as some intrinsic tumor factors are associated with increased risk of recurrence. However, large scale prospective studies are needed to truly answer this question 6 . The microscopic pattern of TGCT can be variable based on the proportion of mononuclear cells, multinucleate giant cells, foamy macrophages (xanthoma cells), hemosiderin-laden macrophages and the amount of stroma present. Osteoclastlike giant cells may be readily apparent, but can be rare in highly cellular lesions. The morphology of the mononuclear cells usually consists of small cells which are either round or spindled. Cytologically, these cells show round to kidneyshaped nuclei with occasional grooves as well as a pale cytoplasm. In addition, more epitheloid-appearing cells with round, vesicular nuclei and glassy cytoplasm are seen. Foamy xanthoma cells are often seen and tend to occur at the edge of the lesion ( Figure 2C ). Hemosiderin is extremely common. The stroma may show extensive hyalinization (Figure 2A ) and give the lesion a lobular architecture. Mitotic activity is not uncommon, and this should not be misinterpreted as evidence of malignancy. Necrosis, however, is rare. In many cases, the mononuclear cells will show positivity for desmin. Though this does not, rare cases may show near diffuse positivity which may mimic rhabdomyosarcoma. Immunohistochemistry is not required for the diagnosis 1,2 . TGCTs commonly overexpress colony-stimulating factor 1 (CSF1). In many patients, CSF1 overexpression results from a t(1;2) translocation, which fuses the CSF1 gene to the collagen type VI α3 (COL6A3) promoter. Imatinib mesylate (IM) blocks CSF1 receptor and has been used in treatment for diffuse type TGCT 3, 4 . Other entities to include in the histologic differential diagnosis include giant cell granuloma (giant cell reparative granuloma) which can involve the bones of the hand. Giant cell granuloma is thought to evolve in response to injury. This entity is typically unencapsulated and shows reactive bone with osteoblastic rimming. Giant cell tumor of bone (osteoclastoma) is uncommon in the hand 1 . 
